Physician profile
Michael Bertnice Scott
NPI 1609963750
$2,347.23
in general payments reported to CMS, 2019-2025
16 companies · $188 in 2025
The $188 reported for 2025 was more than what a typical Pediatric Urology provider received nationally (typical 2025 total: $127).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $398 · 2020: $167 · 2021: $181 · 2022: $310 · 2023: $406 · 2024: $697 · 2025: $188.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,290.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,290.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $637.93 | 2019-2025 | Xtandi |
| Sumitomo Pharma America, INC. | $286.85 | 2023-2025 | Gemtesa, Orgovyx |
| Abbvie INC. | $228.20 | 2020-2025 | Lupron Depot |
| Coloplast Corp | $217.05 | 2024 | |
| Janssen Biotech, INC. | $213.51 | 2019-2022 | |
| Boston Scientific Corporation | $176.06 | 2019-2024 | Ams 700 |
| Medtronic, INC. | $164.01 | 2023 | Interstim |
| Myovant Sciences Gmbh | $125.00 | 2021 | |
| Urogen Pharma, INC. | $108.22 | 2023-2024 | Jelmyto |
| Bayer Healthcare Pharmaceuticals INC. | $50.07 | 2023-2024 | |
| Novo Nordisk INC | $34.17 | 2025 | Rivfloza |
| Myovant Sciences INC. | $25.37 | 2022 | |
| Procept Biorobotics Corporation | $22.77 | 2022 | |
| Dentsply Ih INC. | $21.24 | 2019 | |
| Telix Pharmaceuticals | $19.20 | 2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $17.58 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Scott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.